Terms: = Gastric cancer AND MN1, Q10571, MGCR1-PEN, MGCR1, MGCR, dJ353E16_2, ENSG00000169184, 4330 AND Treatment
14415 results:
1. Real-world safety and effectiveness of anamorelin for cancer cachexia: Interim analysis of post-marketing surveillance in Japan.
Takayama K; Kojima A; Honda C; Nakayama M; Kanemata S; Endo T; Muro K
Cancer Med; 2024 May; 13(9):e7170. PubMed ID: 38693813
[TBL] [Abstract] [Full Text] [Related]
2. Clinical impact of skeletal muscle mass change during the neoadjuvant chemotherapy period in patients with gastric cancer: An ancillary study of JCOG1002.
Sato R; Tokunaga M; Mizusawa J; Sato Y; Ito S; Takahari D; Sano T; Onaya H; Yoshikawa T; Boku N; Terashima M
World J Surg; 2024 Jan; 48(1):163-174. PubMed ID: 38686798
[TBL] [Abstract] [Full Text] [Related]
3. Risk factors associated with lymph node metastasis in early-stage distal gastric cancer.
Yu Z; Liang C; Li R; Gao J; Gao Y; Zhou S; Li P
World J Surg; 2024 Jan; 48(1):151-162. PubMed ID: 38686759
[TBL] [Abstract] [Full Text] [Related]
4. EBV-Associated gastric cancer; An In Situ Hybridization Assay on Tissue Microarray: A Multi-Region Study from Four Major Provinces of Iran.
Abolhasani M; Mohseni AO; Shakeri R; Khavanin A; Khajehei M; Omidi A; Geramizadeh B; Shafigh E; Naghshvar F; Fathizadeh P; Taghizadehgan L; Gharib A; Gulley ML; Dawsey SM; Malekzadeh R; Rabkin CS; Vasei M
Arch Iran Med; 2024 Apr; 27(4):191-199. PubMed ID: 38685845
[TBL] [Abstract] [Full Text] [Related]
5. Comprehensive multi-omics analysis of resectable locally advanced gastric cancer: Assessing response to neoadjuvant camrelizumab and chemotherapy in a single-center, open-label, single-arm phase II trial.
Zhao Y; Li D; Zhuang J; Li Z; Xia Q; Li Z; Yu J; Wang J; Zhang Y; Li K; Xu S; Li S; Ma P; Cao Y; Liu C; Xu C; Liu Z; Wei J; Zhang C; Qiao L; Gao X; Hou Z; Liu C; Zheng R; Wang D; Liu Y
Clin Transl Med; 2024 May; 14(5):e1674. PubMed ID: 38685486
[TBL] [Abstract] [Full Text] [Related]
6. Characteristics of early gastric tumors with different differentiation and predictors of long-term outcomes after endoscopic submucosal dissection.
Zhu HY; Wu J; Zhang YM; Li FL; Yang J; Qin B; Jiang J; Zhu N; Chen MY; Zou BC
World J Gastroenterol; 2024 Apr; 30(14):1990-2005. PubMed ID: 38681129
[TBL] [Abstract] [Full Text] [Related]
7. treatment of Cachexia in gastric cancer: Exploring the Use of Anti-Inflammatory Natural Products and Their Derivatives.
Loyala JV; Down B; Wong E; Tan B
Nutrients; 2024 Apr; 16(8):. PubMed ID: 38674936
[TBL] [Abstract] [Full Text] [Related]
8. ACAT2 suppresses the ubiquitination of YAP1 to enhance the proliferation and metastasis ability of gastric cancer via the upregulation of SETD7.
Zhang M; Cai F; Guo J; Liu S; Ma G; Cai M; Zhang R; Deng J
Cell Death Dis; 2024 Apr; 15(4):297. PubMed ID: 38670954
[TBL] [Abstract] [Full Text] [Related]
9. The Important Role of GPX1 and NF-κB Signaling Pathway in Human gastric cancer: Implications for Cell Proliferation and Invasion.
Jang BI; Jung JY; Koh SA; Lee KH
Cancer Genomics Proteomics; 2024 Apr; 21(3):305-315. PubMed ID: 38670589
[TBL] [Abstract] [Full Text] [Related]
10. Creatinine-to-cystatin C ratio and body composition predict response to PD-1 inhibitors-based combination treatment in metastatic gastric cancer.
Ji H; Liu B; Jin P; Li Y; Cui L; Jin S; Wu J; Shan Y; Zhang Z; Ming J; Zhang L; Du C
Front Immunol; 2024; 15():1364728. PubMed ID: 38665913
[TBL] [Abstract] [Full Text] [Related]
11. Efficacy and safety of biosimilar trastuzumab (CT-P6) in routine clinical practice in the Republic of Korea: a real-world post-marketing surveillance study.
Park MH; Seo JH; Park JH; Seong MK; Park KU; Kim MK; Chang M; Koh SJ; Lee MH; Lim ST; Yoo YB; Oh SY; Kim SH; Ahn KY; Park TH; Ju H; Baek EH; Kim S; Kim N; Lee E; Kim TH
Expert Opin Biol Ther; 2024 Apr; 24(4):305-312. PubMed ID: 38664937
[TBL] [Abstract] [Full Text] [Related]
12. Microbiome signatures associated with clinical stages of gastric cancer: whole metagenome shotgun sequencing study.
Jeong S; Liao YT; Tsai MH; Wang YK; Wu IC; Liu CJ; Wu MS; Chan TS; Chen MY; Hu PJ; Kao WY; Liu HC; Tsai MJ; Liu CY; Chang CC; Wu DC; Hsu YH
BMC Microbiol; 2024 Apr; 24(1):139. PubMed ID: 38658841
[TBL] [Abstract] [Full Text] [Related]
13. Integrated multi-omics analysis and machine learning developed a prognostic model based on mitochondrial function in a large multicenter cohort for gastric cancer.
Ma Y; Jin J; Xue Z; Zhao J; Cai W; Zhang W
J Transl Med; 2024 Apr; 22(1):381. PubMed ID: 38654380
[TBL] [Abstract] [Full Text] [Related]
14. [The efficacy and safety of laparoscopic radical gastrectomy after neoadjuvant chemotherapy combined with immunotherapy and targeted therapy].
Shao XX; Li WK; Hu HT; Lu YM; Jiang YJ; Tian YT
Zhonghua Yi Xue Za Zhi; 2024 Apr; 104(16):1397-1402. PubMed ID: 38644290
[No Abstract] [Full Text] [Related]
15. [Clinical significance of immune checkpoint inhibitors in neoadjuvant therapy for gastric cancer].
Zhu ZG
Zhonghua Yi Xue Za Zhi; 2024 Apr; 104(16):1331-1336. PubMed ID: 38644278
[TBL] [Abstract] [Full Text] [Related]
16. [Therapeutic efficacy analysis of endoscopic combined with serological diagnosis strategy and endoscopic in G1 and G2 gastric neuroendocrine neoplasms].
Li WY; Liu Y; Zhang YM; Dou LZ; He S; Ke Y; Liu XD; Liu YM; Wu HR; Wang GQ
Zhonghua Zhong Liu Za Zhi; 2024 Apr; 46(4):326-334. PubMed ID: 38644268
[No Abstract] [Full Text] [Related]
17. [Enhancing survival outcomes in stage Ⅲ gastric/esophagogastric junction cancer: a retrospective study of immune checkpoint inhibitors and adjuvant chemotherapy based on real-world data].
Yang XQ; Rao Z; Wei HK; Xue ZC; Liu HY; Duan QF; Sun XW; Wang W
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):395-402. PubMed ID: 38644245
[No Abstract] [Full Text] [Related]
18. Over-the-scope clip as a rescue treatment for massive bleeding due to Dieulafoy lesion at the colorectal anastomosis: A case report.
Han P; Li D; Guo Q; Lei Y; Liu J; Tian D; Yan W
Medicine (Baltimore); 2024 Apr; 103(16):e37871. PubMed ID: 38640308
[TBL] [Abstract] [Full Text] [Related]
19. Amlodipine inhibits Synaptotagmin-4's oncogenic activity on gastric cancer proliferation by targeting calcium signaling.
Huang W; Yang S; Deng M; Luo R; Liang H; Shen Y; Yang B; Xu C; Hou Y
Funct Integr Genomics; 2024 Apr; 24(3):77. PubMed ID: 38632140
[TBL] [Abstract] [Full Text] [Related]
20. Nivolumab-Induced Cytokine Release Syndrome: A Case Report and Literature Review.
Ntwali F; Gilliaux Q; Honoré PM
Am J Case Rep; 2024 Apr; 25():e941835. PubMed ID: 38625840
[TBL] [Abstract] [Full Text] [Related]
[Next]
